ALISON BODEN: Open Payments
NPI 1053881995 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,337 in 56 payments from 17 companies in 2025. Trend: 2023 $611 · 2024 $906 · 2025 $1,337
Food & beverage: $1,153Education: $184
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $312 |
| ABBVIE INC. | 10 | $165 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $127 |
| Regeneron Healthcare Solutions, Inc. | 6 | $113 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| UCB, Inc. | 4 | $92 |
| Janssen Biotech, Inc. | 4 | $87 |
| Galderma Laboratories, L.P. | 3 | $51 |
| Botanix SB Inc | 2 | $49 |
| Arcutis Biotherapeutics, Inc. | 2 | $41 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, TREMFYA, NEMLUVIO, SOFDRA, RINVOQ, ILUMYA.
Industry payments across FL — which companies pay providers there.
